Family-owned multinational enterprises in the post-pandemic global economy.

Contractor (J Int Bus Stud, 2022 ) argues that the COVID-19 pandemic has only accelerated changes in the world economy that had already started, and that the fundamental rationale for globalization remains. Although we agree with much of Contractor's analysis and conclusions, we argue that in the case of large family-owned multinational enterprises (MNEs), international behavior after the pandemic is likely to be varied, reflecting the strategic persistence and the heterogeneity of the goals, governance, and resources of these firms compared to nonfamily firms. We therefore complement Contractor's article by discussing why most large family MNEs will pursue strategies that are consistent with globalization, but some will pursue strategies that move them in the opposite direction.

One year in review 2016: novelties in the treatment of rheumatoid arthritis.

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.

One year in review 2015: Sjögren's syndrome.

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease mainly characterised by the inflammation of exocrine glands; however, a broad spectrum of systemic manifestations may characterise the disease. Recently, pSS has been the object of considerable immunologic and clinical research which has led to significant advances in the diagnosis, prognostic assessment and management of the disease. Herewith, we provide a critical digest of the recent literature on this topic.